Reconstituting a BPC-157 and TB-500 blend starts with adding bacteriostatic water, then gently swirling until the powder dissolves. For a typical 5 mg/5 mg vial, adding 2 mL of bacteriostatic water yields a concentration of 2.5 mg/mL of each peptide, and a standard daily dose of 500 mcg of each requires drawing 0.2 mL on an insulin syringe. This guide walks through every step, including a dosage calculator, for researchers in Canada.
Why Reconstitute a BPC-157 TB-500 Blend Correctly
BPC-157 and TB-500 are often combined in a single vial for research on tissue repair and recovery. Both peptides are lyophilized powders that must be mixed with bacteriostatic water before injection. Proper reconstitution preserves peptide integrity and ensures accurate dosing. In Canada, these blends are available through research chemical suppliers, but handling errors can degrade the peptides or cause dosing mistakes.
BPC-157 is a pentadecapeptide derived from gastric juice, known for promoting angiogenesis and accelerating healing of tendons, ligaments, and the gut. TB-500 is a synthetic fragment of thymosin beta-4, which regulates actin and supports cell migration and wound repair. Together, they are studied for synergistic effects on muscle recovery and injury rehabilitation. Reconstituting them as a blend simplifies administration but requires careful calculation to deliver the intended dose of each peptide.
BPC-157 TB-500 Dosage Calculator: How to Determine Your Draw Volume
The most common blend vial contains 5 mg of BPC-157 and 5 mg of TB-500. To calculate your dose, you need to know the total volume of bacteriostatic water added. Use this formula: desired dose (mg) divided by concentration (mg/mL) equals draw volume (mL). For a 500 mcg dose of each peptide with 2 mL of water added, the math is 0.5 mg / 2.5 mg/mL = 0.2 mL.
Here is a quick reference for a 5 mg/5 mg blend vial:
- Add 1 mL bacteriostatic water: concentration = 5 mg/mL each. For 500 mcg dose, draw 0.1 mL (10 units on an insulin syringe).
- Add 2 mL bacteriostatic water: concentration = 2.5 mg/mL each. For 500 mcg dose, draw 0.2 mL (20 units).
- Add 3 mL bacteriostatic water: concentration = 1.67 mg/mL each. For 500 mcg dose, draw 0.3 mL (30 units).
Always double-check your math. A common error is forgetting that the blend contains two peptides at equal mass, so the concentration applies to each individually. If your research protocol calls for different doses of BPC-157 and TB-500, a pre-mixed blend may not be suitable unless the ratio matches your needs.
Step-by-Step Reconstitution Process for BPC-157 TB-500
Follow these steps to reconstitute your BPC-157 TB-500 blend safely. Use sterile technique throughout to avoid contamination.
- Gather supplies: You will need the lyophilized peptide vial, a vial of bacteriostatic water, alcohol swabs, and an insulin syringe with a removable needle (typically 1 mL, 29–31 gauge).
- Clean the tops: Wipe the rubber stoppers of both vials with an alcohol swab and let them dry completely.
- Draw bacteriostatic water: Attach a needle to the syringe, pull the plunger back to your desired volume of air, insert the needle into the water vial, inject the air, then draw the water. For a 2 mL reconstitution, you may need to do this twice with a 1 mL syringe.
- Add water to peptide vial: Insert the needle into the peptide vial at an angle, aiming the stream against the glass wall to avoid foaming. Slowly push the plunger to release the water.
- Swirl gently: Do not shake. Roll the vial between your fingers or gently swirl until the powder completely dissolves. The solution should be clear and free of particles.
- Store properly: Keep the reconstituted peptide in the refrigerator at 2–8°C. Avoid freezing. Use within 30 days for best stability, though some studies suggest potency may last longer if handled aseptically.
If the solution remains cloudy or has visible particles, do not use it. This could indicate contamination or incomplete dissolution.
Choosing the Right Bacteriostatic Water for Reconstitution
Bacteriostatic water is sterile water containing 0.9% benzyl alcohol as a preservative. It inhibits bacterial growth and allows multi-dose use from the same vial. In Canada, bacteriostatic water is available from research supply vendors, often sold alongside peptides. Do not use sterile water for injection without a preservative unless you plan to use the entire vial immediately, as it lacks antimicrobial protection.
Some researchers ask about using acetic acid for BPC-157 because early studies used it for solubility. However, modern BPC-157 is formulated as a stable salt that dissolves readily in bacteriostatic water. Using acetic acid adds unnecessary complexity and can sting upon injection. Stick with bacteriostatic water for both peptides in the blend.
Common Reconstitution Mistakes and How to Avoid Them
Even experienced researchers make errors. Here are the top mistakes when reconstituting a BPC-157 TB-500 blend in Canada or elsewhere:
- Shaking the vial: Vigorous shaking can denature the peptides. Always swirl gently.
- Incorrect volume calculation: Misplacing a decimal point can lead to a 10-fold dosing error. Use a dosage calculator or double-check your math.
- Using tap water or saline: Only bacteriostatic water is appropriate. Saline can cause peptide aggregation.
- Injecting air directly into the powder: This can blow the lyophilized cake around and cause loss. Aim the water stream at the glass wall.
- Reusing needles: Always use a new, sterile needle for each step to prevent contamination.
Dosing Protocols for BPC-157 TB-500 Blend Research
In animal studies and anecdotal human reports, typical doses range from 250 mcg to 500 mcg of each peptide once or twice daily. For a 5 mg/5 mg blend reconstituted with 2 mL of water, a 500 mcg dose of each requires a 0.2 mL injection. Some protocols use a loading phase of 500 mcg twice daily for the first week, then reduce to once daily for maintenance.
TB-500 is often dosed slightly higher in standalone studies (2.5–5 mg twice weekly), but in blends, the equal ratio limits flexibility. If your research requires a higher TB-500 dose, consider separate vials. For localized healing, injections are often administered subcutaneously near the injury site, though systemic effects occur with any injection location.
Cycle length in research typically spans 4–6 weeks, followed by a break to assess sustained benefits. Long-term safety data in humans is limited, so protocols should be conservative.
Where to Buy BPC-157 TB-500 Blend in Canada
Researchers in Canada can source BPC-157 and TB-500 blends from domestic peptide suppliers that ship within the country. These products are sold for research purposes only and are not approved for human use by Health Canada. When purchasing, look for vendors that provide third-party purity testing via HPLC and mass spectrometry. A certificate of analysis should confirm the peptide content and absence of contaminants.
Prices for a 5 mg/5 mg blend vial typically range from $60 to $120 CAD, depending on the supplier and any ongoing promotions. Some vendors offer combo kits that include bacteriostatic water and syringes, which can simplify the process for new researchers. Always verify that the supplier ships from within Canada to avoid customs delays, as peptide imports can be scrutinized.
While this guide focuses on reconstitution, understanding the broader context of peptide research can be valuable. For instance, researchers interested in metabolic peptides might compare Tesamorelin and Semaglutide for visceral fat reduction, which highlights different mechanisms of action. Similarly, those studying hormonal influences on healing could explore Semaglutide use during menopause to see how GLP-1 agonists interact with physiological changes. And for a deeper look at peptide safety profiles, Semaglutide and bone health data provides insights into long-term effects.
Stability and Storage After Reconstitution
Once reconstituted, the BPC-157 TB-500 blend should be kept refrigerated. Peptides in solution are susceptible to degradation by heat, light, and bacterial growth. Bacteriostatic water extends the usable life to about 30 days when stored properly. Some researchers report using vials for up to 60 days without apparent loss of effect, but this is not recommended for critical studies.
To maximize stability, minimize the number of times the vial stopper is punctured. Use a single syringe to draw multiple doses if you are comfortable with aseptic technique, but never reuse a needle that has touched any non-sterile surface. If you notice any change in color, clarity, or odor, discard the vial immediately.
Frequently Asked Questions About BPC-157 TB-500 Reconstitution
Can I reconstitute BPC-157 and TB-500 separately and then mix them?
Yes, if you have individual vials, you can reconstitute each with bacteriostatic water and then draw both into the same syringe for injection. This allows flexible dosing but requires two vials and careful calculation. A pre-mixed blend is more convenient but locks you into a fixed ratio.
What syringe size is best for injecting the blend?
Insulin syringes with 0.3 mL, 0.5 mL, or 1 mL capacity and a 30-gauge, 8 mm needle are ideal for subcutaneous injections. The smaller barrel makes it easier to measure small volumes accurately. For a 0.2 mL dose, a 0.3 mL or 0.5 mL syringe is perfect.